arrow
L

Liang Peng

Sun Yat sen University
H指数:26
被引数:4,637

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection in the High-Replicative Low-Inflammatory Phase: A 48-Week Randomized Controlled Trial

替诺福韦艾拉酚胺在治疗高复制低炎症期慢性乙型肝炎病毒感染中的应用:一项为期48周随机对照试验

2026-05-070
OAAI
Nicotinamide mononucleotide promotes osteogenesis and reduces adipogenesis by regulating mesenchymal stromal cells via the SIRT1 pathway in aged bone marrow (vol 10, 336, 2019)

烟酰胺单核苷酸通过SIRT1通路调控间充质基质细胞,促进成骨作用并抑制脂肪生成,在老年骨髓中发挥作用(卷10,336,2019)。

2025-03-110
OA
A multicenter, open-label phase II study to evaluate the efficacy and safety of pimicotinib (CSF-1R inhibitor) in combination with chemotherapy with or without toripalimab in patients (pts) with advanced pancreatic ductal adenocarcinoma (aPDAC)

一项多中心、开放标签的II期研究,旨在评估pimicotinib(CSF-1R抑制剂)联合化疗,在有或无toripalimab的情况下,在患有晚期胰腺导管腺癌(aPDAC)的患者(pts)中的有效性和安全性。

2024-09-010
PRE